Last year, Avanos Medical Inc generated 432.90M USD for its biggest-performing segment, Digestive Health. The North America made the largest contribution, accounting for 543.90M USD last year. For the latest quarter, Avanos Medical Inc reported the revenue of 124.00M USD for the period ending 2026-03-31, which came from the top-performing segment, Digestive Health. North America contributed the highest revenue, at 137.10M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Digestive Health

Pain Management

Chronic Care

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Digestive Health

432.90M(61.74%)

396.40M(57.63%)

371.60M(55.19%)

340.40M(49.76%)

--(--)

Pain Management

268.30M(38.26%)

291.40M(42.37%)

301.70M(44.81%)

343.70M(50.24%)

264.80M(35.56%)

243.60M(34.08%)

283.90M(40.70%)

Chronic Care

--(--)

479.80M(64.44%)

471.20M(65.92%)

413.70M(59.30%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

North America

Europe, Middle East and Africa

Asia Pacific and Latin America

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

North America

543.90M(77.57%)

545.00M(79.24%)

537.90M(79.89%)

552.00M(80.69%)

561.60M(75.42%)

535.50M(74.92%)

534.70M(76.65%)

Europe, Middle East and Africa

102.80M(14.66%)

94.80M(13.78%)

84.10M(12.49%)

77.40M(11.31%)

105.10M(14.11%)

108.30M(15.15%)

95.80M(13.73%)

Asia Pacific and Latin America

54.50M(7.77%)

48.00M(6.98%)

51.30M(7.62%)

54.70M(8.00%)

77.90M(10.46%)

71.00M(9.93%)

67.10M(9.62%)